Atlas Trials

qQ-lab Daily-IBS for Irritable Bowel Syndrome

Clinical trial NCT03964103 · COMPLETED

Trial details

NCT number
NCT03964103
Sponsor
IlDong Pharmaceutical Co Ltd
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Irritable Bowel Syndrome (IBS)
Start date
2016-10-04
Primary completion
2017-11-08
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.